Related Experiment Videos
Managing antipsychotic-induced parkinsonism
D C Mamo1, R A Sweet, M S Keshavan
1Department of Psychiatry, University of Pittsburgh School of Medicine, Philadelphia, USA. mamodc@msx.upmc.edu
Drug Safety
|April 30, 1999
Summary
Conventional antipsychotics can cause parkinsonism, a common side effect. Early detection through bedside exams and appropriate management strategies, including medication adjustments or antiparkinsonian drugs, are crucial for patient well-being and treatment adherence.
Area of Science:
- Psychiatry
- Neurology
- Pharmacology
Background:
- Conventional ('typical') antipsychotics are widely used despite newer agents.
- Antipsychotic-induced parkinsonism is a frequent adverse effect impacting patient morbidity and treatment compliance.
Purpose of the Study:
- To review the prevalence, detection, and management of antipsychotic-induced parkinsonism.
- To discuss pharmacological strategies for managing this adverse effect.
Main Methods:
- Literature review on antipsychotic-induced parkinsonism.
- Analysis of management strategies including drug selection and prophylactic use.
Main Results:
- Bedside examination is effective for early parkinsonism detection, especially within the first 3 months of treatment.
- Management options include dosage reduction, switching antipsychotics, or using antiparkinsonian drugs.
- Anticholinergic agents are primary for younger patients; amantadine is better tolerated in the elderly.
- Prophylactic anticholinergics are not recommended routinely and are contraindicated in the elderly.
Conclusions:
- Regular monitoring for antipsychotic-induced parkinsonism is essential for patient comfort and optimizing antipsychotic dosage.
- Individualized risk-benefit assessment is necessary when considering prophylactic treatment, particularly in younger patients.